Deal done: Why the CSL (ASX:CSL) share price is in focus
Jaz Harrison
August 2, 2022
The CSL Limited (ASX:CSL) share price is making headlines today
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
The CSL Limited (ASX:CSL) share price is making headlines today
Graham Witcomb, CFA of The Intelligent Investor joins Owen Rask
The S&P/ASX 200 (INDEXASX: XJO) started Tuesday with a mixed
The Australian share market, otherwise known as S&P/ASX 200 (INDEXASX:
It’s been a crazy few months, hasn’t it? Rates, Elections,
The ASX 200 (ASX:XJO) couldn’t overcome growing concerns about stagflation
The technology sector all but sunk the S&P/ASX 200 (ASX:
The S&P/ASX 200 (INDEXASX:XJO) eked out a small gain on
The S&P/ASX 200 (ASX:XJO) fell another 1.2% to start the
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
